118. 脊髄髄膜瘤 Myelomeningocele Clinical trials / Disease details

臨床試験数 : 10 / 薬物数 : 18 - (DrugBank : 7) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 12

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04652908 (ClinicalTrials.gov)	June 21, 2021	25/11/2020	Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial	Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele	Myelomeningocele	Biological: Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracell ...	Diana Lee Farmer	California Institute for Regenerative Medicine (CIRM)	Recruiting	19 Weeks	25 Weeks	All	55	Phase 1/Phase 2	United States
2	NCT04738539 (ClinicalTrials.gov)	March 2, 2021	1/2/2021	Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies	Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies	Myelomeningocele;Neurogenic Bladder;Tethered Cord Syndrome;Bladder, Neurogenic;Urologic Diseases;Neu ...	Drug: Contrast Enhanced Voiding Urosonography with Urodynamic Testing;Diagnostic Test: Urodynamic Te ...	University of Virginia	NULL	Recruiting	N/A	18 Years	All	105		United States
3	JPRN-UMIN000040088	2019/07/01	07/04/2020	Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele	Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele- Safety Assessment Clinical Te ...	Myelomeningocele	MMC(Myelomeningocele) open fetal surgery	OSAKA UniversityDepartment of MedicineDivision of Obstetrics and Gynecology	NULL	Recruiting	20years-old	Not applicable	Female	15	Not selected	Japan
4	NCT04027374 (ClinicalTrials.gov)	July 1, 2019	16/7/2019	Stress-associated Epigenetic Alterations in Newborns After Fetal Surgery	Epigenetic Alterations in Stress Regulation Genes Among Newborns After Fetal Surgery for Myelomening ...	Meningomyelocele	Procedure: Fetal surgery for MMC repair	University Children's Hospital, Zurich	University of Zurich;Psychiatric University Hospital, Zurich	Recruiting	N/A	3 Months	All	90		Switzerland
5	NCT03936322 (ClinicalTrials.gov)	May 7, 2019	1/5/2019	Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study	Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study	Spina Bifida;Myelomeningocele;Neural Tube Defects	Device: Minimally invasive fetoscopic repair of MMC	Mayo Clinic	NULL	Active, not recruiting	18 Years	N/A	Female	3	N/A	United States
6	NCT04362592 (ClinicalTrials.gov)	November 2, 2018	24/3/2020	In-Utero Endoscopic Correction of Spina Bifida	In-Utero Endoscopic Correction of Spina Bifida: Laparotomy or Percutaneous	Neural Tube Defects;Spina Bifida;Myelomeningocele	Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique;Device: In U ...	University of Southern California	NULL	Recruiting	18 Years	52 Years	Female	33	N/A	United States
7	NCT02390895 (ClinicalTrials.gov)	May 17, 2017	15/2/2015	Prenatal Endoscopic Repair of Fetal Spina Bifida	Prenatal Endoscopic Repair of Fetal Spina Bifida	Myelomeningocele	Procedure: endoscopic repair of myelomeningocele before 26 SA	Assistance Publique - Hôpitaux de Paris	NULL	Active, not recruiting	18 Years	N/A	Female	7	N/A	France
8	NCT04468568 (ClinicalTrials.gov)	January 8, 2017	1/3/2020	In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline	Assessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, Du ...	Myelomeningocele;Terbutaline Adverse Reaction;Pregnancy; Malformation Central Nervous System	Drug: Atosiban;Drug: Terbutaline	University of Sao Paulo General Hospital	NULL	Recruiting	18 Years	40 Years	Female	28	N/A	Brazil
9	NCT04186338 (ClinicalTrials.gov)	December 1, 2016	2/12/2019	Daily Physical Activity in Myelomeningocele	Daily Physical Activity in Children and Adolescents With Low Lumbar and Sacral Level Myelomeningocel ...	Physical Activity	Device: Omnidirectional accelerometer monitor (3x3 cm and 16 g, Actical®, Philips Respironics)	Marmara University	NULL	Completed	6 Years	16 Years	All	20		NULL
10	NCT00175123 (ClinicalTrials.gov)	May 2005	9/9/2005	Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele	Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Child ...	Myelomeningocele;Bladder, Neurogenic	Drug: Botulinum A toxin	University of Aarhus	Aarhus University Hospital	Active, not recruiting	2 Years	16 Years	Both	30	Phase 4	Denmark

First Previous1Next Last